In March 2025, the company announced new plans for any direct-to-customer presenting of its Wegovy weight loss drug. The company recognized a new pharmacy, termed NovoCare, which might cost customers $499 each month for access to the drug, lower than fifty percent the price of the drug by way of other pharmaceutical distribution networks.[fifty thr